Talk:Cara Tannenbaum
Latest comment: 2 years ago by Soulsinsync in topic Response To Proposed Edits
This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page. |
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||||||||||
|
Proposed Edits
editI am acting on behalf of Cara Tannenbaum to flag the following inaccuracies:
- Since 2005, she has been the Scientific Director of Canadian Institutes of Health Research's Institute of Gender and Health.[1][2] The two references for this sentence indicate that Dr. Tannenbaum has held this position since 2015, not 2005.
- She is now a professor of medicine and pharmacy at the Université de Montréal, where she conducts research at the Centre de recherche de l’Institut universitaire de gériatrie de Montréal, and also is the director of the Canadian Deprescribing Network (CaDeN). Dr. Tannenbaum is a former director of the Canadian Deprescribing Network, but is no longer serving in this role.[3] Reference #5 is also a broken link. Suggestion to replace with: https://criugm.qc.ca/en/chercheurs/tannenbaum-cara-en/.
I would also like to propose the following additions:
- Dr. Tannenbaum was appointed as the Departmental Science Advisor for Health Canada in 2019. [4]
- Dr. Tannenbaum co-founded the CanCOVID network in 2020.[5][6][7]
- Dr. Tannenbaum has received several awards and honors since the article was last updated. For example: Canadian Science Policy Centre Exceptional Contribution to Science Policy Award: Trailblazer (2020)[8]; Society of Chemical Industry Purvis Memorial Award (2020)[9]; American Society for Clinical Pharmacology & Therapeutics William B. Abrams Awards in Geriatric Clinical Pharmacology (2021).[10]
DanielleNadin (talk) 15:58, 20 December 2021 (UTC)
References
- ^ https://medecine.umontreal.ca/2014/11/18/cara-tannenbaum-nommee-directrice-scientifique-linstitut-sante-femmes-hommes-irsc/
- ^ https://cihr-irsc.gc.ca/e/50878.html
- ^ https://www.deprescribingnetwork.ca/directors
- ^ https://science.gc.ca/eic/site/063.nsf/eng/h_98245.html#cara-tannenbaum
- ^ https://physics.uwo.ca/news_events/making_headlines/2020-2021/sarah_gallagher_is_corecipient_of_the_purvis_memorial_award_from_the_canadian_society_of_chemical_industry.html
- ^ https://swahn.ca/Uploads/ContentDocuments/Press%20Release_%20English%20(3).pdf
- ^ https://www.computecanada.ca/blog/in-conversation-with-mark-daley-on-the-cancovid-platform/
- ^ https://sciencepolicy.ca/conference/cspc-2020/trailblazer-award-winner/
- ^ https://www.soci.org/awards/past-recipients/purvis-memorial-award
- ^ https://www.ascpt.org/Portals/28/docs/Awards/Criteria%20and%20Past%20Recipients/2021%20Awards/Award%20Criteria%20and%20Past%20Recipients%202021%20WB%20Abrams.pdf?ver=2021-05-03-114941-207
Response To Proposed Edits
editI have reviewed the proposed edits now and updated the inaccuracies on the Wikipedia page. Soulsinsync (talk) 19:12, 8 January 2022 (UTC)